Breaking News, Collaborations & Alliances

Evotec, Novo Nordisk Ink Deal to Develop Off-the-Shelf Cell Therapies

Novo Nordisk to provide funding for technology development activities at Evotec to support clinical & commercial manufacturing of stem cell-based therapies.

Author Image

By: Charlie Sternberg

Associate Editor

Evotec has entered a technology development partnership with Novo Nordisk to provide next-generation off-the-shelf cell therapy products for clinical development and possible commercialization after that. The companies will also collaborate on the development of advanced technologies in support of their cell therapy collaboration.   Both Evotec and Novo Nordisk have significant expertise and a strategic focus to support stem cell-based therapies.   Under the collaboration agreement, Novo Nor...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters